Cargando…

Elotuzumab for multiple myeloma

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427619/
https://www.ncbi.nlm.nih.gov/pubmed/36110178
http://dx.doi.org/10.18773/austprescr.2022.040
_version_ 1784778946493022208
collection PubMed
description
format Online
Article
Text
id pubmed-9427619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-94276192022-09-14 Elotuzumab for multiple myeloma Aust Prescr New Drugs NPS MedicineWise 2022-07-07 2022-08 /pmc/articles/PMC9427619/ /pubmed/36110178 http://dx.doi.org/10.18773/austprescr.2022.040 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Elotuzumab for multiple myeloma
title Elotuzumab for multiple myeloma
title_full Elotuzumab for multiple myeloma
title_fullStr Elotuzumab for multiple myeloma
title_full_unstemmed Elotuzumab for multiple myeloma
title_short Elotuzumab for multiple myeloma
title_sort elotuzumab for multiple myeloma
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427619/
https://www.ncbi.nlm.nih.gov/pubmed/36110178
http://dx.doi.org/10.18773/austprescr.2022.040